Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : ASK Vendit Off Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: brk who wrote (18815)	2/6/2001 2:56:13 AM
From: rx4pain	Respond to of 19374

brk-IMNX, don't know what to do with it. Certainly appears to have bottomed. Temporarily anyway. Downtrend for at least last 6 months. Steeper downtrend since middle of December. Doesn't really fit into the old school pharmaceutical sector. Not genomics. Definitely biotech, but only 1 of a handful making money. However, profits are entirely constrained by supply, and they can't increase supply for at least a year.(For Enbrel). Couple a 135 PE with no growth, and you got a downtrend confirmed on a graph. Oversold? I don't know, looking elsewhere in the mean time. Rx